Analytical goals for the determination of HbA₂.

We present a study aimed to define the analytical goals for the determination of hemoglobin A₂, a minor hemoglobin present in human blood normally accounting from 2.5 % to 3.3 % of total hemoglobin, and typically increased up to 6 % – 7 % in subjects carriers of β-thalassemia.
The analytical goals have been derived using two approaches, the first one based on biologic variation, and the second one based on the opinion of experts.
The data obtained by studying 17 adult non-carrier healthy subjects, from whom we took blood samples every 2 weeks for 2.0 months, indicated a small intraindividual biologic variation (CV I of 0.7 % ), with respect to a larger between-subject variation (CV G of 7.7 % ). The minimum levels for imprecision, bias and total error derived from the analysis of these data were: 0.5 % , 2.9 % and 4.5 % , respectively. The limits derived from the opinion of experts were based on a questionnaire with three clinical cases, which was circulated among two teams of international experts, and on a discussion about the clinical needs. The average total error derived from such surveys ranged between 7.0 % and 9.5 % .
The various methods to derive analytical performance goals gave different limits, thus indicating the need for an increased communication between clinicians and laboratory professionals on this matter.
Authors Andrea Mosca, Renata Paleari, Barbara Wild,
JournalClinical chemistry and laboratory medicine (Clin Chem Lab Med) Vol. 51 Issue 5 Pg. 937-41 (May 2013) ISSN: 1437-4331 [Electronic] Germany
PMID23027585 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Hemoglobin A2
  • Adult
  • Female
  • Healthy Volunteers
  • Hemoglobin A2 (analysis)
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: